Long-term Outcomes Following Active Surveillance of Low-grade Prostate Cancer: A Population-based Study Using a Landmark Approach. Letter

J Urol. 2023 Sep;210(3):410. doi: 10.1097/JU.0000000000003614. Epub 2023 Jul 14.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Humans
  • Male
  • Neoplasm Grading
  • Prostate
  • Prostate-Specific Antigen
  • Prostatic Neoplasms* / epidemiology
  • Prostatic Neoplasms* / therapy
  • Watchful Waiting*

Substances

  • Prostate-Specific Antigen